Open Access
Short Case Report
Issue
J Oral Med Oral Surg
Volume 25, Number 3, 2019
Article Number 22
Number of page(s) 3
Section Cas clinique / Short case report
DOI https://doi.org/10.1051/mbcb/2019006
Published online 07 May 2019
  1. Doumas S, Vladikas A, Papagianni M, Kolokotronis A. Human cytomegalovirus-associated oral and maxillo-facial disease. Clin Microbiol Infect 2007;13:557-559 [CrossRef] [PubMed] [Google Scholar]
  2. Mainville GN, Marsh WL, Allen CM. Oral ulceration associated with concurrent herpes simplex virus, cytomegalovirus, and Epstein-Barr virus infection in an immunocompromised patient. Oral Surg Oral Med Oral Pathol Oral Radiol 2015;119(6):306-314 [CrossRef] [Google Scholar]
  3. Tnani N, Massoumi A, Lortholary O, Soussan P, Prinseau JA, Baglin A, et al. Prise en charge de l'infection à cytomégalovirus symptomatique chez les patients traités par immunosuppresseurs pour une maladie inflammatoire chronique. Rev Med Interne 2008;29:305-310 [CrossRef] [PubMed] [Google Scholar]
  4. Lee MY, Chiou TJ, Hsiao LT, Yang MH, Lin PC, Poh SB, et al. Rituximab therapy increased post-transplant cytomegalovirus complications in Non-Hodgkin's lymphoma patients receiving autologous hematopoietic stem cell transplantation. Ann Hematol 2008;87:285-289 [CrossRef] [PubMed] [Google Scholar]
  5. Keogh KA, Ytterberg SR, Fervenza FC, Carlson KA, Schroeder DR, Specks U. Rituximab for refractory Wegener's granulomatosis: Report of a prospective, open-label pilot trial. Am J Respir Crit Care Med 2006;173:815-816 [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.